Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
By Anthony Hughes ยท Bloomberg Markets
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.